Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension

Intradialytic Hypertension Clinical Trial

Official title:
Mechanism of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension and Hemodialysis Controls: A Case Control Study and Crossover Trial Comparing Carvedilol and Prazosin Hydrochloride

Status Completed

Clinical Trial Summary

The purpose of this study is 1) to determine what physiologic factors (extracellular fluid overload or vasoconstriction) contribute more to increased blood pressure levels between dialysis treatments in hemodialysis patients whose blood pressure increases and decreases during hemodialysis and 2) to determine whether carvedilol provides better control of blood pressure between dialysis treatments than prazosin in patients whose blood pressure increases during dialysis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01862497
Study type	Observational
Source	University of Texas Southwestern Medical Center
Contact
Status	Completed
Phase
Start date	January 2013
Completion date	April 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03038165` - Hemodynamic Parameters Changes in the Course of Hemodialysis Sessions in Patients With Intradialytic Hypertension
Completed	`NCT01371890` - Mechanisms and Treatment of Intradialytic Hypertension - Sodium
Completed	`NCT00827775` - Mechanisms and Treatment of Intradialytic Hypertension	Phase 4
Completed	`NCT05430438` - Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension	N/A
Completed	`NCT01916668` - A Cross-sectional Study on Intradialytic Hypertension at Four Haemodialysis Units in the Western Cape	N/A